Abstract
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b]difuran-4-yl)-2-aminopropane; ‘ B-fly’). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon
Keywords: ABDF, Bromo-Dragonfly, FLY-compounds, internet monitoring, phenethylamines, designer drugs, ReDNet project, research chemicals, psychoactive drugs
Current Clinical Pharmacology
Title: Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly
Volume: 6 Issue: 2
Author(s): Liv Flesland, Norbert Scherbaum, Peer Van Der Kreeft, Cinzia Pezzolesi, Arvid Skutle, Holger Siemann, Harry Shapiro, Agnieszka Pisarska, Jacek Moskalewicz, Barbara Mervo, Ornella Corazza, Lucia Di Furia, Zsolt Demetrovics, Marta Torrens, Colin Drummond, Zoe Davey, Paolo Deluca, Magi Farre and Fabrizio Schifano
Affiliation:
Keywords: ABDF, Bromo-Dragonfly, FLY-compounds, internet monitoring, phenethylamines, designer drugs, ReDNet project, research chemicals, psychoactive drugs
Abstract: Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b]difuran-4-yl)-2-aminopropane; ‘ B-fly’). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon
Export Options
About this article
Cite this article as:
Flesland Liv, Scherbaum Norbert, Van Der Kreeft Peer, Pezzolesi Cinzia, Skutle Arvid, Siemann Holger, Shapiro Harry, Pisarska Agnieszka, Moskalewicz Jacek, Mervo Barbara, Corazza Ornella, Di Furia Lucia, Demetrovics Zsolt, Torrens Marta, Drummond Colin, Davey Zoe, Deluca Paolo, Farre Magi and Schifano Fabrizio, Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly, Current Clinical Pharmacology 2011; 6 (2) . https://dx.doi.org/10.2174/157488411796151129
DOI https://dx.doi.org/10.2174/157488411796151129 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships
Current Alzheimer Research Hydroxytyrosol, a Phenyl Ethyl Alcohol with Health Effects
Current Organic Chemistry Commentary: Neurorestoratology: A Concept and Emerging Discipline in the Treatment of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Nitric Oxide, Peroxynitrite, Peroxynitrous Acid, Nitroxyl, Nitrogen Dioxide, Nitrous Oxide: Biochemical Mechanisms and Bioaction
Current Bioactive Compounds Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis
Infectious Disorders - Drug Targets Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?
Current Topics in Medicinal Chemistry The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
Current Molecular Medicine The Effects of P75NTR on Learning Memory Mediated by Hippocampal Apoptosis and Synaptic Plasticity
Current Pharmaceutical Design The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
Current Neuropharmacology Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls
Current Psychiatry Reviews The Quinolone Family: From Antibacterial to Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Postoperative Clinical Monitoring After Morphine Administration: A Retrospective Multicenter Practice Survey
Current Drug Safety The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy
Current Neuropharmacology Pharmacogenomics: Integration into Drug Discovery and Development
Current Topics in Medicinal Chemistry Pharmacogenetics of Phase I and Phase II Drug Metabolism
Current Pharmaceutical Design Roles of Nicotinic Acetylcholine Receptors in Stem Cell Survival/Apoptosis, Proliferation and Differentiation
Current Molecular Medicine A Review of Computational Identification of Protein Post-Translational Modifications
Mini-Reviews in Organic Chemistry Synthesis, Conformational Analysis and Crystal Structure of New Thioxo, Oxo, Seleno Diastereomeric Cyclophosphamides Containing 1,3,2-dioxaphosphorinane
Current Organic Chemistry